Nephrotic-range proteinuria following pamidronate therapy in a patient with metastatic breast cancer: mitochondrial toxicity as a pathogenetic concept?
Sauter
Matthias
M
Medizinische Poliklinik, Klinikum-Innenstadt, University of Munich, Germany. matthias.sauter@med.uni-muenchen.de
Jülg
Boris
B
Porubsky
Stefan
S
Cohen
Clemens
C
Fischereder
Michael
M
Sitter
Thomas
T
Schlondorff
Detlef
D
Gröne
Hermann-Josef
HJ
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D001706:Biopsy; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary; D001943:Breast Neoplasms / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000473:pathology; D004164:Diphosphonates / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004848:Epithelium / Q000503:physiopathology; D005260:Female; D005923:Glomerulosclerosis, Focal Segmental / Q000139:chemically induced / Q000150:complications / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology / Q000648:ultrastructure; D008875:Middle Aged; D008928:Mitochondria / Q000187:drug effects* / Q000502:physiology / Q000648:ultrastructure; D009362:Neoplasm Metastasis / Q000188:drug therapy; D000077268:Pamidronate; D011507:Proteinuria / Q000139:chemically induced* / Q000209:etiology
D000970:Antineoplastic Agents; D004164:Diphosphonates; D000077268:Pamidronate